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Abstract
Mammalian oviduct acts as a reservoir for spermatozoa and provides an environment in which they may compete for
the opportunity to fertilize the oocyte. Whilst in the oviduct spermatozoa undergo capacitation essential for
fertilization. Sperm-oviduct interaction is essential for sperm capacitation and is a tightly regulated process influenced
by the local microenvironment. Previously we reported that the endocannabinoid anandamide (AEA) regulates sperm
release from epithelial oviductal cells by promoting sperm capacitation. The aims of this work were to measure the
AEA content and to characterize the main AEA metabolic pathway in the bovine oviduct and determine how these
change through the oestrous cycle. In this study, the levels of AEA and two other N-acylethanolamines, N-
oleoylethanolamine and N-palmitoylethanolamine, were measured in bovine oviduct collected during different stages
of oestrous cycle by ultra high performance liquid chromatography tandem mass spectrometry. Results indicated that
intracellular oviductal epithelial levels of all three N-acylethanolamines fluctuate during oestrous cycle. Anandamide
from oviductal fluid also varied during oestrous cycle, with the highest values detected during the periovulatory
period. Endocannabinoid levels from ipsilateral oviduct to ovulation were higher than those detected in the
contralateral one, suggesting that levels of oviductal AEA may be regulated by ovarian hormones. The expression
and localization of N-acylethanolamines metabolizing enzymes in bovine oviduct were also determined by RT-PCR,
Western blot, and immunohistochemistry but no change was found during the oestrous cycle. Furthermore,
nanomolar levels of AEA were detected in follicular fluids, suggesting that during ovulation the mature follicle may
contribute to oviductal AEA levels to create an endocannabinoid gradient conducive to the regulation of sperm
function for successful fertilization.
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Introduction
The oviduct plays a key role in the physiology of reproduction
by providing a beneficial environment for gamete maturation
and transport, fertilization and early embryo development
during its subsequent passage to the uterus. It also acts as a
functional sperm reservoir providing an environment where
these compete for the fertilization of the oocyte.
In different mammalian species, spermatozoa are
sequestered in the proximal region of the oviduct (isthmus)
where they attach to epithelial cells, delaying sperm
capacitation until ovulation-associated signals induce their
release allowing their transit to the distal region of the oviduct
(ampulla) [1].
Products of each oviductal segment (i.e. isthmus and
ampulla), oviductal epithelial cells, as well as oviductal fluid are
necessary for normal and efficient oviductal functions [2].
In general, mating and natural insemination in most
mammalian species only take place during a specific phase of
the reproductive cycle. Sperm-oviduct interactions that precede
fertilization are undoubtedly influenced by the dynamics of the
hormonal environment [3,4]. In addition, some molecules such
as, glycosaminoglycans, present in oviductal secretions play a
role in these sperm-oviduct interactions and bovine sperm
capacitation [5–8]. The concentrations of these compounds in
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oviductal luminal fluid are under cyclic ovarian control, reaching
a peak during the period of oestrus [7]. One group of such
compounds is the endocannabinoids.
The endocannabinoid (EC) system refers to a group of lipid
mediators, enzymes involved in their synthesis and
degradation, such as N-acyl-phosphatidylethanolamine
phospholipase D (NAPE-PLD) and fatty acid amide hydrolase
(FAAH), respectively and their receptors that are involved in a
variety of physiological processes including many reproductive
functions. N-arachidonoylethanolamide or anandamide (AEA)
is an EC that activates the specific cannabinoid receptors 1
(CB1) and 2 (CB2) and also activates the transient receptor
potential vanilloid type I (TRPV1) ion channel. Several studies
have shown that AEA is widely distributed in the mammalian
reproductive tissues and fluids (oviduct, oviductal fluid, uterus,
testis, seminal plasma, spermatozoa) and is involved in many
reproductive functions such as sperm motility and capacitation,
ovulation, embryo implantation, and oviductal embryo transport
[9–15].
Other compounds that belong to the class of bioactive N-
acylethanolamines (NAEs) include N-oleoylethanolamide
(OEA) and N-palmitoylethanolamide (PEA). These are
‘endocannabinoid-like’ congeners that are thought to modulate
the effects of AEA at the cannabinoid receptors by inhibiting its
degradation, resulting in a prolongation of its biological effect
[16–19]. Anandamide, OEA and PEA are present in human
seminal plasma, mid-cycle oviductal fluid, follicular fluid,
amniotic fluid and milk [20,21].
Endocannabinoids act locally, and their local concentrations
are tightly regulated by a balance between their synthesis and
degradation by NAPE-PLD and FAAH enzymes, respectively
[22].
The EC system has recently been characterized in both
mammalian oviduct and sperm cells [14,23–25]. Previously, we
have demonstrated that bovine oviductal epithelial cells
(BOEC) and bull spermatozoa express CB1, CB2, TRPV1 and
FAAH [26,27]. Our findings also indicated that AEA signaling
regulates sperm-oviduct interaction. Since sperm detachment
may be due to surface remodelling by capacitation, we also
demonstrated that nanomolar concentrations of AEA induce
sperm capacitation in bull spermatozoa [27].
Oviductal secretions create an appropriate environment for
the final maturation and capacitation of spermatozoa. The
protein and lipid contents of oviductal fluid change during the
oestrous cycle [4]. Recently, many studies have described an
interplay between the EC system and reproductive hormones
in the control of male and female reproductive physiology
[28–30]. In women, AEA tone changes during the menstrual
cycle; a peak of plasma AEA occurs at ovulation and positively
correlates with estradiol and gonadotrophin levels, suggesting
that FSH and LH may be involved in the regulation of AEA
levels [31]. In addition, FAAH activity changes in mouse uterus
during the estrous cycle [32], and ovarian steroids like estradiol
and progesterone are negative modulators of it [33,34].
Table 1. Levels of NAEs in oviductal fluid at different stages
of the oestrous cycle in the bovine oviduct.
Days of
oestrous
cycle Ipsilateral Contralateral
 
AEA
(nM)
OEA
(nM) PEA (nM) n
AEA
(nM)
OEA
(nM) PEA (nM) n
1-5 0.46 ±0.12
6.62 ±
0.72
19.37 ±
6.32 6
0.29 ±
0.07
5.04 ±
0.65
31.53 ±
15.49 5
6-12 0.41 ±0.05
4.7 ±
0.63
21.64 ±
8.19 12
0.27 ±
0.04
3.38 ±
0.41
11.74 ±
2.53 9
13-18 0.37 ±0.06
5.47 ±
0.46
11.54 ±
2.05 14
0.3 ±
0.04
4.59 ±
0.34 2.41 ± 9 14
19-21 0.45 ±0.13
5.09 ±
0.66
21.67 ±
7.64 6
0.39 ±
0.11
5.89 ±
0.91
19.8 ±
3.8 6
Samples of oviductal fluid were collected and NAEs were measured by UHPLC-
MS/MS. Ipsilateral: oviduct ipsilateral to ovulation site/corpus luteum/dominant
follicle. Contralateral: oviduct contralateral to ovulation site/corpus luteum/dominant
follicle.
Figure 1.  Endocannabinoid levels in the bovine oviductal fluid.  Oviducts were classified as ipsilateral and contralateral oviduct
to ovulation. A) AEA levels, Ipsilateral: n = 38; Contralateral: n = 34; a ≠ b, P<0.05 B) OEA levels, Ipsilateral n = 33; Contralateral: n
= 30. C) PEA levels Ipsilateral n= 35; Contralateral: n= 29.
doi: 10.1371/journal.pone.0072521.g001
Endocannabinoids in Bovine Oviduct
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Furthermore, several studies suggest that these also exist an
interplay between ECs and signals regulating pregnancy and or
labour confirming a tight crosstalk between EC and sex
hormones [28,35].
Of relevance is the fact that in rodents, a relationship
between the spatiotemporal expression of AEA metabolic
enzymes and its oviductal concentration has been
demonstrated [10]. A critical balance has also been described
between AEA synthesis and degradation resulting in the
creation of a locally appropriate ‘anandamide tone’ required for
normal embryo development, oviductal transport, implantation,
and pregnancy.
We speculate that changes occur in oviductal AEA and its
metabolite concentrations during the bovine oestrous cycle and
furthermore that these, may be involved in sperm-oviduct
interaction.
The aims of this work were therefore to firstly characterize
such oviductal changes in AEA and then to investigate
Figure 3.  Measurement of intracellular NAEs from bovine oviductal epithelial cells.  A) Intracellular AEA content in the
different stages of the oestrous cycle, n = 15. B) Intracellular AEA content in different regions of the oviduct, n = 30. C) Intracellular
OEA content at different stages of the oestrous cycle, n = 15. D) Intracellular OEA in different regions of the oviduct, n = 30. E)
Intracellular PEA content at different stages of the estrous cycle, n = 15. F) Content of PEA in different regions of the oviduct, n =
30. a ≠ b ≠ c, P<0.05.
doi: 10.1371/journal.pone.0072521.g003
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Figure 2.  Correlation between different NAEs measured in
bovine oviductal fluids.  A) Positive correlation between AEA
and OEA, n=63; Spearman correlation coefficient = 0.53;
P<0.001. B) No correlation between AEA and PEA was
observed, n= 64; P = 0.83. C) No correlation between OEA and
PEA was observed, n = 55; P= 0.1.
doi: 10.1371/journal.pone.0072521.g002
changes to the main AEA metabolic enzymes throughout the
bovine oestrous cycle.
Materials and Methods
Chemicals
AEA, OEA, PEA, and deuterated internal standards of
anandamide (AEA-d8), N-oleoylethanolamide (OEA-d2) and N-
palmitoylethanolamide (PEA-d4) were obtained from Cayman
Chemicals (Ann Arbor, MI). Acetonitrile, methanol and
ammonium acetate, each of high performance liquid
chromatography grade, were purchased from Fisher Scientific
(Loughborough, UK) and HPLC grade water was obtained
using a water purification system (Maxima ELGA, ELGA, High
Wycombe, UK). All mobile phases were filtered through 0.2-
µm, 4- to 7-mm-diameter PTFE filters (Waters Ltd., Elstree,
UK) prior to use.
Anti-NAPE-PLD (for immunohistochemistry and western blot)
and anti-FAAH (for immunohistochemistry) rabbit polyclonal
antibody were obtained from Abcam and Abbiotec,
respectively. The secondary goat anti-rabbit horseradish
peroxidase conjugates used were from Dako (Glostrup,
Denmark). An ABC detection system (ABC Elite; Vector
Laboratories, Peterborough, UK) was used in conjunction with
3,3’-diaminobenzidine (Vector Laboratories) to detect the
presence of immunoreactive complexes.
Sample collection
Bovine oviducts were obtained from two slaughterhouses,
Joseph Morris Butchers ltd (South Kilworth, Leicestershire, UK)
and Frigorífico Rioplatense SAICIF (Buenos Aires, Argentina).
Slaughterhouses gave the necessary permissions for the organ
collections. The oviducts were immediately placed on ice and
transported to the laboratory. According to the ovarian and
corpus luteum morphology, the oviducts were classified into
one of four different stages of the oestrous cycle: post-
ovulatory (days 1-5), early-to-mid luteal (days 6-12), late luteal
(days 13-18), and pre-ovulatory (days 19-21) phases [36]. In
addition, the oviducts of each cow were separated into
ipsilateral (to ovulation site/corpus luteum/dominant follicle) or
contralateral. The oviducts were cleaned of surrounding tissues
and the ampulla and isthmus regions were then separated and
then the oviductal content was collected by squeezing
(applying pressure) with tweezers. After that, BOEC were
separated from the oviductal fluid by centrifugation at 800 g for
5 min at 4oC. The supernatants from the oviductal fluid
(between 10 and 30 µl) were immediately processed for NAEs
determination while the obtained cell pellets were stored at
-80°C until further analysis.
In addition, between 100 and 500 µl of bovine follicular fluid
were collected by aspiration with a syringe from follicles
present in the ovaries. The follicles were classified according to
their diameter into large (diameter > 1 cm) or small (diameter <
1 cm) follicles. The follicular fluid from each follicle was
thereafter collected into Kimble Scintillation vials for
measurement of NAEs.
Endocannabinoids in Bovine Oviduct
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Preparation of internal standards
AEA and AEA-d8 were diluted in acetonitrile to make stock
solutions of 5 mg/ml and 100 µg/ml, respectively. OEA and
PEA were dissolved in ethanol at 10 mg/ml and 2,5 mg/ml,
respectively. OEA-d2 (1 µg/µl) and PEA-d4 (1 µg/µl) stocks
were supplied as ethanol stocks and stored at -20°C. Further
dilutions were carried out in acetonitrile on ice to generate
working internal standards solution of AEA-d8 (62.5pmol/ml),
OEA-d2 (62.5pmol/ml) and PEA (125pmol/ml).
Table 2. Levels of NAEs in oviductal epithelial cells from
bovine oviducts.
 Ipsilateral n Contralateral n
AEA (nM) 90.32 ± 9.26 a 31 73.21 ± 5.92 a 29
OEA (nM) 327.82 ± 31.36 a 31 287.06 ± 24.53 a 29
PEA (nM) 252.34 ± 27.02 a 29 198.33 ± 28.53 b 27
Samples of BOEC were collected and NAEs were measured by UHPLC-MS/MS.
Ipsilateral: BOEC from the oviduct ipsilateral to ovulation site/corpus luteum/
dominant follicle. Contralateral: BOEC from the oviduct contralateral to ovulation
site/corpus luteum/dominant follicle.
NAEs determination
Oviductal fluid.  To avoid complications arising from
endogenous NAE present in the samples, extraction
efficiencies from oviductal fluid were determined by the
recoveries of the internal standards compared with non-
extracted stocks of the same concentration. For quantification
of NAEs in oviductal fluid working internal standards solution
and oviductal fluid were mixed at a ratio of 1:1 (v/v) and diluted
in acetonitrile to a final volume of 50 µl. The samples were
mixed thoroughly and cooled at -20°C for 10 min to precipitate
all proteins before the samples were centrifuged at 3000 g for 1
min at 4°C and the supernatants were transferred to HPLC
sample vials ready for UHPLC-MS/MS analysis as described
previously [37].
Epithelial cells.  The BOEC from the ampulla and isthmus
were resuspended in either 500 or 200 µl of lysis buffer PBS
with [0.02% (w/v) sodium azide, 0.1% (w/v) SDS, 1% (v/v)
Nonidet P-40, 0.5% (w/v) sodium deoxycholate], respectively
and thereafter were sonicated for 30 sec. The internal
standards (2.5 pmol/ml of AEA-d8 and OEA-d2; 5 pmol/ml of
PEA-d4) were then added and the samples were diluted to 1 ml
with deionized water. All samples were vortexed thoroughly
and centrifuged at 15,000 g for 5 min at 4°C. The supernatants
were collected and transferred to a clean 7-ml Kimble
scintillation vial (Kinesis, St. Neots, Cambs, UK). The solid-
Figure 5.  mRNA and protein expression of NAPE-PLD in the bovine oviduct during the oestrous cycle.  A) Representative
picture of NAPE-PLD and actin mRNA levels (n = 6). B) Relative optical densitometry (OD) analysis related to actin band. Ampulla
and Isthmus: oviductal regions. C) BOEC proteins were extracted and subjected to SDS-PAGE and immunoblotted with a specific
antibody against NAPE-PLD (n=6). D) Relative optical densitometry (OD) analysis was normalised to actin levels. Ampulla and
Isthmus: oviductal regions.
doi: 10.1371/journal.pone.0072521.g005
Endocannabinoids in Bovine Oviduct
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Figure 4.  Correlation between NAE levels measured in the
oviductal epithelial cells.  A) Positive correlation between
AEA and OEA, n = 60, Spearman correlation coefficient = 0.66;
P<0.001. B) Positive correlation between AEA and PEA, n =
56, Spearman correlation coefficient = 0.67; P<0.001. C)
Positive correlation between OEA and PEA, n = 56, Spearman
correlation coefficient = 0.51; P<0.001.
doi: 10.1371/journal.pone.0072521.g004
phase method for EC extraction was performed as previously
described [21]. Briefly, Oasis HLB 1cc cartridges (Waters) were
preconditioned and equilibrated using 1 ml of methanol and 1
ml of water via a vacuum manifold (Waters). Samples were
introduced onto the cartridges and drawn under gentle vacuum.
The cartridges were washed with 1 ml of 40% aqueous
methanol, and NAEs were eluted in 1 ml of acetonitrile. The
eluate was dried under a constant stream of nitrogen,
reconstituted in 80 µl of acetonitrile, and transferred to an
HPLC sample vial ready for UHPLC-MS/MS analysis as
described previously [37]. NAE concentrations were normalized
to protein concentration which was determined by the Bradford
method [38].
Follicular fluid.  The follicular fluid (between 100 and 500 µl)
was spiked with AEA-d8 (2.5 pmol/ml), OEA-d2 (2.5 pmol/ml)
and PEA-d4 (5 pmol/ml) internal standards, and diluted with
deionized water to a final volume of 1 ml. The samples were
vigorously vortexed and the NAEs were extracted using the
solid-phase method described above.
Measurement of FAAH and NAPE-PLD mRNA
expression
Total RNA was isolated from BOEC using Trizol reagent
(Invitrogen) according to the manufacturer’s recommendations.
The concentration of RNA was determined by
spectrophotometry by measuring the absorbance at 260 nm.
Only samples with a 260nm/280nm ratio greater than 1.6 were
used for further analysis. cDNA was synthesized from 1 µg
total mRNA using Maloney Murine Leukemia Virus Reverse
Transcriptase (M-MLVRT) and random primers (Invitrogen),
according to the manufacturer’s instructions in the presence of
recombinant RNase inhibitor. After first-strand synthesis, PCR
was performed with the following oligonucleotide primers:
FAAH transcript: 5’-CTGCCAAGCAACATACCTCA-3’ (sense),
5’-GGCTGATAACCTTGGGAACA-3’ (antisense); NAPE-PLD
transcript: 5’-AGATTTGGCCCTTTTGACCT-3’ (sense), 5’-
CTTCACACAGTTTCGCTGGA-3’ (antisense); α-actin
transcript: 5’-AGGCGGACTGTTAGCTGCGTT-3’ (sense), 5’-
TGCTCGATCCAACCGACTGCT-3’ (antisense). Amplifications
were performed using Taq DNA polymerase enzyme
(Invitrogen).
PCR was performed as follows: 94°C for 5 min (initial
denaturation) and for FAAH and actin 35 cycles at 94°C for 40
s, 55°C for 40 s, and 72°C for 40 s; for NAPE-PLD 35 cycles at
94°C for 40 s, 56°C for 40 s, and 72°C for 40 s. Negative
controls were performed without cDNA template. PCR products
were separated on a 2% (w/v) agarose gel, stained with
ethidium bromide and recorded under u.v. light with a digital
camera (Olympus C5060).
Western blotting analysis
FAAH and NAPE-PLD protein expression were determined
by western blotting analysis using specific antibodies. BOEC
from ampulla or isthmus were incubated with lysis buffer
containing 10 µg/ml leupeptin, 2 µg/ml aprotinin, 100 µg/ml
soybean trypsin inhibitor, 1mM EDTA, 1 mg/ml benzamidine,
10 µg/ml dithiothreitol, 1 mg/ml caproid acid, and 1 mM sodium
orthovanadate. Oviductal cells were sonicated for 30 s and
Endocannabinoids in Bovine Oviduct
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Figure 6.  Localization of NAPE-PLD enzyme in the bovine oviduct.  NAPE-PLD is mainly localized in the oviduct epithelial cells
and circular muscle layer of the ampulla and isthmus. Panels c and f correspond to negative control: by the replacement of the
specific primary antibody by serum from non-immunized rabbits at the same concentration. The images are representative from at
least three oviducts and taken at 50x (a and d), 200x (b, c, e and f). Scale bar (a and d) = 250 µm; scale bar (b,c, e and f) = 100 µm.
doi: 10.1371/journal.pone.0072521.g006
Figure 7.  mRNA and protein expression of FAAH in the bovine oviduct during the oestrous cycle.  A) Representative picture
of FAAH and actin mRNAs (n = 6). B) Relative optical densitometry (OD) analysis normalised to actin expression. C) BOEC protein
were extracted and subjected to SDS-PAGE and immunoblotted with a specific antibody against FAAH (n=6). D) Relative optical
densitometry (OD) analysis normalised to actin expression. Ampulla and Isthmus: oviductal regions.
doi: 10.1371/journal.pone.0072521.g007
Endocannabinoids in Bovine Oviduct
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then centrifuged at 2000 g for 10 min. Protein determination
was assayed by the Bradford method using BSA as standard.
BOEC proteins (80 µg/ml) were separated using 10% SDS-
PAGE and subsequently transferred to nitrocellulose
membranes. Membrane non-specific binding sites were
blocked with [2% (w/v) of fat-free milk powder] and incubated
with primary anti-FAAH [1:500 (v/v)], anti-NAPE-PLD [1:2500
(v/v)] or anti-actin [1:4000 (v/v)] antibodies followed by
incubations with goat anti-rabbit HRP-conjugated IgG [1:10000
(v/v)]. Immunoreactive specificity was assessed by omitting the
first antibody. Bands were visualized using chemiluminescence
detection reagents and an Image Quant system (GE
Healthcare, Buckinghamshire, UK).
Immunohistochemistry
The procedures for immunodetection of FAAH and NAPE-
PLD were performed as previously described [15]. Slides
containing tissue sections were dewaxed in xylene three times
for 3 min each time and rehydrated in graded alcohol followed
by incubation in distilled water. Endogenous peroxidase activity
was then blocked by incubation in 6% H2O2 in water for 10 min.
Oviductal sections were incubated with blocking solution
(10% v/v normal goat serum) for 20 min at room temperature
and incubated with anti- FAAH (1:100) or anti-NAPE-PLD
(1:1000) primary antibody overnight at 4 °C. The FAAH or
NAPE-PLD antibodies were incubated with normal rabbit
serum (DAKO) diluted to the same concentration as control.
Samples were washed in tris-buffered saline (TBS; 0.5 M
Trizma, 1.5 M NaCl, 2 mM MgCl2, pH =7.6) for 20 min and
then incubated with a biotinylated secondary antibody for 30
min at room temperature. After washing in TBS, ABC Elite
reagent was applied according to the manufacturer’s detailed
instructions. After washing, 3,3’-diaminobenzidine was added
to each sample for 5 min. Slides were then washed in distilled
water for 5 min before counterstaining in Mayer’s hematoxylin
for 30 s. After washing in running tap water for 5 min, slides
were dehydrated in graded alcohols for 5 min each, cleared
through xylene twice for 5 min each and mounted using
butylphthalate xylene (DPX) mounting medium (BDH, Poole,
Dorset, UK).
Measurement of fatty acid amide hydrolase (FAAH)
activity
FAAH activity was assessed as previously described [39] in
BOEC from the ampulla and isthmus at different stages of the
oestrous cycle. The hydrolysed [3H]-AA (tritiated arachidonic
acid) was resolved into the organic layer of a solvent system of
ethyl acetate: hexane: acetic acid: distilled water
[100:50:20:100 (v/v)] mixture. The plate was exposed to iodine
Table 3. FAAH activity at different stages of the oestrous
cycle in the bovine oviduct.
Days of oestrous
cycle Ampulla Isthmus
 
FAAH activity (nmol
AA/h/mg prot) n
FAAH activity (nmol
AA/h/mg prot) n
1-5 112.30 ± 27.96 5 104.83 ± 16.44 5
6-12 83.90 ± 14.58 4 71.23 ± 7.76 3
13-18 91.70 ± 16.14 4 95.02 ± 22.70 5
19-21 89.92 ± 12.53 5 89.32 ± 16.18 5
FAAH activity was assessed in BOEC from the ampulla and isthmus at different
stages of the oestrous cycle.
Figure 8.  Localization FAAH enzyme in the bovine oviduct.  FAAH enzyme was also localized in the epithelial and circular
smooth muscle layers of the ampulla and isthmus. Panels c and f correspond to negative control: by the replacement of specific
primary antibody by serum from non-immunized rabbits at the same concentration. The images are representative from at least
three oviducts and taken at 50x (a and d), 200x (b, c, e and f).
Scale bar (a and d) = 250 µm; scale bar (b,c, e and f) = 100 µm.
doi: 10.1371/journal.pone.0072521.g008
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to identify the [3H]-AA areas. The distribution of radioactivity on
the plate was counted in a scintillation counter by scraping off
the corresponding spots detected in the plate. The area of each
radioactive peak corresponding to [3H]-AA was calculated and
expressed as a percentage of the total radioactivity of the
plates. Enzyme activity is reported as nmol [3H]-AA/mg
protein/h. Protein concentration was determined as previously
described [38].
Statistical analysis
Statistical analyses were performed using the software
Infostat 2011 (Di Rienzo J.A., Casanoves F, Balzarini M.G.,
González L, Tablada M, Robledo C.W. InfoStat versión 2011.
Grupo InfoStat, FCA, Universidad Nacional de Córdoba,
Argentina).
Data were expressed as mean ± SEM. As the data were
normally distributed and presented homogeneity of variances,
parametric tests were used. Comparison between groups was
performed with a two-way analysis of variance (ANOVA)
followed by Tukey’s honestly significant difference test. Data
from oviductal fluid were assessed taking into account the site
of the oviduct and the stages of the oestrous cycle. Data from
epithelial cells were assessed taking into account the stage of
the oestrous cycle and the region of the oviduct (ampulla or
isthmus).
Spearman correlation was used to evaluate the relationship
between different variables. When P<0.05 the differences were
considered to be significant.
Results
Determination of NAEs content in the oviductal fluid
during oestrous cycle
Endocannabinoid levels from oviductal fluid at different
stages of the oestrous cycle were comparable (Table 1).
Nanomolar AEA levels fluctuated slightly, but there was no
statistically significant difference in the ipsilateral and
contralateral oviducts throughout the oestrous cycle and up to
ovulation. There were, however, higher AEA levels in the
ipsilateral side compared to the contralateral one (Figure 1A; P
< 0.05).
Oleoylethanolamide and PEA were also present at
nanomolar concentrations in the oviductal fluid (Table 1).
However AEA concentration was 10 and 40 times lower when
compared to OEA and PEA, respectively. There were no
significant differences in OEA and PEA concentrations
between ipsilateral and contralateral oviducts (Figure 1B and
1C).
The relationships between NAEs levels in oviductal fluid are
shown in Figure 2. There were highly statistically significant
positive correlations between AEA and OEA levels in oviductal
fluid (Figure 2A; P < 0.001). No correlations were found
between AEA and PEA or between OEA and PEA (Figure 2B
and 2C).
Measurement of intracellular NAEs content during
oestrous cycle
We also evaluated AEA, OEA and PEA content in oviductal
epithelial cells from the two regions of the oviduct (ampulla or
isthmus). Figure 3A shows that the highest AEA levels were
found in the periovulatory stages (days 1-5 and days 19-21)
compared with the early to mid-luteal and luteal stages (days
6-12 and 13-18 respectively) (P<0.05). No significant
differences were found between the ampulla and isthmus
(Figure 3B).
Intracellular levels of OEA and PEA demonstrated similar
changes to those for AEA through the oestrous cycle, however,
the levels differed significantly (P<0.05) among regions of the
studied oviduct (Figures 3C, 3D, 3E and 3F). In both cases,
measured levels were higher in the ampulla than the isthmus
and these were elevated in the periovulatory stages (days 1-5
and days 19-21) compared to the other stages.
In contrast to results obtained for oviductal fluid, intracellular
levels of AEA from BOEC did not differ significantly between
the ipsilateral or contralateral side to ovulation (Table 2).
However, there were significant differences in intracellular
levels of PEA between the oviducts; highest PEA levels were
found in the ipsilateral oviduct (Table 2).
We also determined the relationship between different NAEs
in BOEC and found that AEA intracellular content correlated
positively with both OEA and PEA intracellular levels (Figure
4A and 4B; P<0.001). Moreover, OEA correlated positively with
PEA (Figure 4C; P < 0.001).
The results thus far indicate that AEA levels fluctuate through
the different stages of the oestrous cycle in the bovine oviduct,
with a higher content of AEA in the ipsilateral oviduct to
ovulation.
Measurement of AEA content from follicular fluid
At ovulation, follicular fluid is released into the peritoneal
cavity and then enters the oviduct. We also determined AEA
levels in the follicular fluid from different size follicles and found
that AEA concentration is significantly higher in small (less than
10 mm) follicles compared to the large follicles (more than 10
mm) (Small Follicle: 1.73 ± 0.1 nM; n= 49/ Large Follicle: 0.97 ±
0.06 nM; n= 37; P<0.01).
Characterization of NAPE-PLD and FAAH enzymes
during bovine oestrus cycle
We therefore proceeded to evaluate the expression and
localization of key enzymes involved in the metabolism of this
EC in ipsilateral oviducts at the different stages of the oestrous
cycle.
We observed that BOEC express both the mRNA and
protein of NAPE-PLD enzyme throughout the oestrous cycle.
NAPE-PLD mRNA was amplified and identified by RT-PCR in
BOEC from the ampulla and isthmus obtained from oviducts at
different stages of the oestrous cycle as a single band at 202
bp (Figure 5A). No significant differences in the mRNA
expression of the enzyme were found in the two oviductal
regions through the oestrus cycle (Figure 5B). NAPE-PLD
protein was detectable as a single band at the expected
molecular mass of 46 KDa in all oviductal stages analyzed
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(Figure 5C). The protein expression of NAPE-PLD did not show
any differences between the oviductal regions and the different
stages of the oestrous cycle (Figure 5D).
Immunohistochemical studies revealed that NAPE-PLD was
present in the oviduct but no differences in expression were
detected between the different stages of the oestrous cycle
(data not shown). In detail, NAPE-PLD was mainly localized in
the epithelial and circular smooth muscle layers of the ampulla
and the isthmus (Figure 6). No immunoreactivity was found
when samples were incubated with the IgG fractions from non-
immunized rabbits (Figure 6) or without the first antibody (data
not shown).
FAAH mRNA was also amplified and identified by RT-PCR in
BOEC at different stages of the oestrous cycle as a single band
at 204 bp (Figure 7A). No significant differences in the mRNA
expression of the enzyme were found in the two oviductal
regions and at different stages of the oestrous cycle (Figure
7B).
FAAH protein expression was readily detectable in the
ampulla and isthmus at different stages and it appeared as a
band at approximately 58 KDa (Figure 7C). Furthermore, when
the protein expression of this enzyme was analyzed at different
stages of the oestrous cycle, no significant differences were
found (Figure 7D).
FAAH localization was also evaluated in the two regions of
the oviduct during the oestrous cycle. FAAH enzyme was
localized in the epithelial and circular smooth muscle layers of
the ampulla and isthmus (Figure 8) with no changes between
the stages of the oestrous cycle (data not shown). No
immunoreactivity was found when slides were incubated with
IgG fractions from non-immunized rabbits (Figure 8) or when
the first antibody was omitted (data not shown).
Furthermore, FAAH activity was measured in BOEC from the
two regions of the oviduct during the oestrous cycle. No
statistically significant changes were found either between
different oestrous cycle stages or between regions (Table 3).
Discussion
In the present work we detected, for the first time, nanomolar
levels of NAEs in the bovine oviduct. We also found that AEA,
OEA and PEA levels fluctuated during the oestrous cycle,
suggesting that oviductal NAEs concentrations could be
controlled by sex hormones.
We have previously reported that AEA is a key molecule
involved in the regulation of sperm release from oviductal
epithelia by promoting sperm capacitation in bovines
[26,27,40]. Ovarian endocrine control is considered the overall
key to completion of capacitation and sperm release from the
oviduct [4], therefore we sought to establish whether oviductal
AEA levels were modified during the oestrous cycle in the
bovine oviduct.
Our results indicate that AEA levels from oviductal fluid were
higher at the ipsilateral oviduct to ovulation compared to the
contralateral oviduct. Moreover, AEA levels fluctuated during
the stages of the oestrous cycle in oviductal fluid with the
highest AEA content found during the periovulatory period in
oviductal epithelial cells. This suggests that AEA may be
synthesized locally in the oviduct under gonadal estrogenic
influence delivered locally. It has been reported that hormones
of low molecular weight such as steroids and prostaglandins
can reach the oviduct from the ovarian vein by counter-current
transfer to the oviduct branch of the ovarian artery [4]. Our
results agree with those reported by [41] who found the highest
plasma AEA level at the time of ovulation in women suggesting
a closer association between AEA and the estradiol peak at
ovulation. In human endothelial cells, Maccarrone, et al. also
demonstrated that AEA release is stimulated by estradiol,
through the stimulation by NAPE-PLD and inhibition by FAAH,
supporting the possibility that estradiol and AEA levels may
also be closely linked in these cells [42,43].
Our data indicate that OEA and PEA also fluctuate during the
oestrous cycle with the highest levels found during the
periovulatory phases. Interestingly, AEA levels positively
correlate with those of OEA in oviductal fluid, however, the
intracellular AEA content correlated both with OEA and PEA
levels. This suggests that in the bovine oviduct, all three NAEs
may be required for oviductal function.
Currently, the precise role that the EC-like compounds play
in the bovine oviduct is unknown. Several authors consider
OEA and PEA as “entourage” compounds that may enhance
the receptor-mediated signaling of AEA, in which these NAEs
inhibit AEA degradation through their ability to compete with
AEA for FAAH, thereby leading to an enhancement of AEA
effects [44–46].
Considering that NAE levels fluctuated through the different
stages of the oestrous cycle in the bovine oviduct, we
evaluated the expression and localization of key enzymes in
the metabolism of this EC in ipsilateral oviducts. FAAH and
NAPE-PLD are considered the “gatekeepers” of EC and EC-
like NAE levels, and their activity and expression determine
local concentrations of these ligands [47].
Previously, we demonstrated the expression of FAAH in
BOEC from unclassified oviducts [26], and here we report for
the first time the expression of FAAH and NAPE-PLD in BOEC
during the different stages of the oestrous cycle. Moreover, in
the present work we determined the localization of these
proteins in the whole bovine oviduct. FAAH and NAPE-PLD
were mainly detected in the oviductal epithelial cells,
supporting the idea that the oviduct can produce NAEs and
contribute to the oviductal AEA tone required for normal
oviductal functions. A previous work reported FAAH and
NAPE-PLD protein localization in the epithelial layer of the
fallopian tube at different stages of the menstrual cycle [48].
Moreover, no differences in neither messenger nor protein
expression of FAAH and NAPE-PLD were found when we
studied the possible modulation of these enzymes during the
oestrous cycle. Oviductal FAAH activity was also not modified
during the oestrous cycle.
We cannot, however, rule out that the increase in NAEs
observed in this work may be secondary to changes in NAPE-
PLD activity. Several studies show opposing effects of ovarian
hormones in the regulation of NAPE-PLD and FAAH
[34,49–52] suggesting that it is hard to predict the effects of the
hormones involved in the regulation of the oestrous cycle on
AEA levels based upon the expression of its metabolic
Endocannabinoids in Bovine Oviduct
PLOS ONE | www.plosone.org 10 August 2013 | Volume 8 | Issue 8 | e72521
enzymes. Also, a number of other synthetic pathways such as
a phospholipase C or a secretory phospholipase A2 have been
proposed in neuronal tissues [53,54] and that have not been
investigated in reproductive tissues which may be modulating
AEA levels. Thus, we thought that direct measurement of AEA
content may be more appropriate.
Although NAPE-PLD and FAAH are the main enzymes
regulating NAEs levels, other enzymes, such as
cyclooxygenase-2 and i-acylethanolamine-hydrolysing acid
amidase have previously been reported to be involved in EC
metabolism [55].
Another possibility is that AEA comes from follicular fluid
released at the time of ovulation. The entry of the products of
ovulation into the ampulla may catalyse the process of sperm
release from the functional reservoir [4]. Our results indicate
that bovine follicular fluid contains AEA at nanomolar
concentration, and thus this might be a source of AEA in the
oviductal fluid during the periovulatory stages. These results
are in agreement with those of Schuel et al. who reported
nanomolar AEA levels in oviductal and follicular fluids obtained
at the mid-cycle of the human menstrual cycle and suggest that
tightly regulated EC levels are crucial for events related to
fertilization, with special emphasis on sperm acquisition of
fertilizing ability [20].
Furthermore the presence of AEA in follicular fluids suggests
that during ovulation, the mature follicle may contribute to
oviductal AEA levels to create an EC gradient conducive to the
regulation of sperm function. The EC gradient was previously
described in the reproductive tract and seems to regulate both
male and female reproductive physiology. For example, a
functional 2-AG gradient regulates mouse epididymal sperm
motility [56] while a gradient of AEA controls the oviductal
transport of embryos and their uterine implantation in the
mouse [28,57]. The fact that AEA levels measured in mature
follicles were lower than those measured in primary follicles
suggests a fine regulation of the AEA metabolism during
folliculogenesis. El-Talatini et al. reported in humans that FAAH
expression is lower in immature follicles than mature ones,
suggesting that the AEA levels from follicular fluid may be
regulated by this enzyme [15].
Sperm are sequentially exposed to different reproductive
fluids such as oviductal and follicular fluid and secretions of the
granulosa cells surrounding ovulated eggs all along the female
tract up to the site of fertilization in the oviduct [58]. The
presence of NAEs in these fluids and the detection of
cannabinoid receptors in bovine spermatozoa [26,27] imply that
NAEs-signaling may regulate sperm capacitation and fertilizing
potential within the bovine reproductive tract.
Our observations suggest that oviductal NAEs levels may be
controlled during the oestrous cycle in bovines and are
important for further understanding of the role of EC (especially
AEA) in the regulation of sperm and oviductal functions in
bovines. Further studies investigating the role of molecules,
such as estradiol, in the regulation of AEA levels are needed to
understand the fine regulation of the EC system in the bovine
oviduct.
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